Cargando…

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery

Detalles Bibliográficos
Autores principales:	Base, E, Standl, T, Mahl, C, Jungheinrich, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092551/ http://dx.doi.org/10.1186/cc4523

Ejemplares similares

Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery
por: Gandhi, S, et al.
Publicado: (2005)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
por: Bepperling, F, et al.
Publicado: (1999)

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
por: Ertmer, C, et al.
Publicado: (2011)

Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation
por: Schick, Martin Alexander, et al.
Publicado: (2015)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
por: Bepperling, F, et al.
Publicado: (1999)

HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function
por: Sossdorf, Maik, et al.
Publicado: (2009)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

The effect of HES130/0.4 sodium chloride solution on kidney function following early fluid resuscitation in shock patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

Does volume substitution with HES 130/0.4 affect renal safety in abdominal aortic surgery?
por: Godet, G, et al.
Publicado: (2006)

The Evaluation of Hydroxyethyl Starch (6% HES 130/0.4) Solution’s Potential Preventive Effects on Coagulation Status in Women with Gynecologic Malignancies Using Rotation Thromboelastography
por: Akay, Meltem Olga, et al.
Publicado: (2014)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis
por: Zampieri, Fernando Godinho, et al.
Publicado: (2013)

6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
por: Margraf, Andreas, et al.
Publicado: (2018)

Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
por: Adamik, Katja-Nicole, et al.
Publicado: (2022)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery
por: Winterhalter, M, et al.
Publicado: (2010)

Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?
por: Esnault, Pierre, et al.
Publicado: (2013)

Is hydroxyethyl starch 130/0.4 safe?
por: Haase, Nicolai, et al.
Publicado: (2012)

Comparison of hydroxyethylstarch (HES 130/0.4) and 5% human albumin for volume substitution in pediatric neurosurgery: A retrospective, single center study
por: Schick, Martin A., et al.
Publicado: (2021)

Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
por: Piazza, Ornella, et al.
Publicado: (2010)

Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
por: Oh, Chung-Sik, et al.
Publicado: (2012)

Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven(®)) at repetitive high dose levels in patients with severe cranio-cerebral trauma
por: Neff, ThA, et al.
Publicado: (2001)

Biomarkers of Coagulation and Inflammation in Dogs after Randomized Administration of 6% Hydroxyethyl Starch 130/0.4 or Hartmann’s Solution
por: Boyd, Corrin J., et al.
Publicado: (2022)

Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study
por: Gurbuz, Hasan Alper, et al.
Publicado: (2013)

Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation Following Complex Heart Surgery
por: Cho, Jang-Eun, et al.
Publicado: (2014)

Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
por: Wong, Yuk Lung, et al.
Publicado: (2015)

Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective
por: Martini, Judith, et al.
Publicado: (2008)

Correction: Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine
Publicado: (2015)

Concerns about renal safety of HES 130
por: Wiedermann, Christian J, et al.
Publicado: (2013)

Comparison of Hydroxyethyl starch 130/0.4 (6%) with commonly used agents in an experimental Pleurodesis model
por: Kapicibasi, Hasan Oğuz, et al.
Publicado: (2020)

Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
por: Wiedermann, Christian J.
Publicado: (2022)

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (C(max))remain unaffected
por: Jungheinrich, C, et al.
Publicado: (2001)

Interactions between the volume effects of hydroxyethyl starch 130/0.4 and Ringer´s acetate
por: Hahn, Robert G, et al.
Publicado: (2013)

Effects of hydroxyethyl starch 130/0.4 on the kidney tissue of rats with ureteral obstruction
por: Güneş, Işın, et al.
Publicado: (2018)

Evaluation of renal injury caused by acute volume replacement with hydroxyethyl starch 130/0.4 or Ringer's lactate solution in pigs
por: Ferreira, David A., et al.
Publicado: (2018)

Renal Morbidity of 6% Hydroxyethyl Starch 130/0.4 in 9000 Propensity Score Matched Pairs of Surgical Patients
por: Miyao, Hideki, et al.
Publicado: (2019)

Evaluation of the Distribution and Elimination of Balanced Isotonic Crystalloid, 5% Hypertonic Saline, and 6% Tetrastarch 130/0.4 Using Volume Kinetic Modeling and Analysis in Healthy Conscious Cats
por: Yiew, Xiu Ting, et al.
Publicado: (2020)

Blood substitutes consumption and coagulation changes: 200/0.5 vs 130/0.4 hydroxyethyl starch administration
por: Costa, MG, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_9ekj5qcd64ijn0s68jp4sjsim6